Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection.

Heart Failure Reviews
Marina RankovicVladimir Jakovljevic

Abstract

Previous studies have demonstrated that individuals with type 2 diabetes mellitus (T2DM) have a two- to fourfold propensity to develop cardiovascular disease (CVD) than nondiabetic population, making CVD a major cause of death and disability among people with T2DM. The present treatment options for management of diabetes propose the earlier and more frequent use of new antidiabetic drugs that could control hyperglycaemia and reduce the risk of cardiovascular events. Findings from basic and clinical studies pointed out DPP-4 inhibitors as potentially novel pharmacological tools for cardioprotection. There is a growing body of evidence suggesting that these drugs have ability to protect the heart against acute ischaemia-reperfusion injury as well as reduce the size of infarction. Consequently, the prevention of degradation of the incretin hormones by the use of DPP-4 inhibitors represents a new strategy in the treatment of patients with T2DM and reduction of CV events in these patients. Here, we discuss the cardioprotective effects of DPP-4 inhibitors as well as proposed pathways that these hypoglycaemic agents target in the cardiovascular system.

References

Jan 10, 2002·Nature·Karim S EchtayMartin D Brand
Sep 30, 2003·Diabetes Care·Daniel J Drucker
Nov 6, 2004·Current Hypertension Reports·Darrell D Belke, Wolfgang H Dillmann
Mar 23, 2005·Regulatory Peptides·Christopher H S McIntoshRaymond Pederson
Jun 17, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Adam M RobinMichael Chopp
Jun 28, 2005·Biochimica Et Biophysica Acta·Hans-Ulrich DemuthRaymond A Pederson
Nov 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Adam M HawkridgeDavid C Muddiman
Dec 13, 2006·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Brian D GreenClifford J Bailey
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Jun 7, 2007·The New England Journal of Medicine·Philip D HomeUNKNOWN RECORD Study Group
Jan 30, 2008·Circulation·Silvio E Inzucchi, Darren K McGuire
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Sep 18, 2009·Expert Opinion on Investigational Drugs·Manfredi RizzoKaspar Berneis
Mar 17, 2010·The American Journal of Medicine·Sunder Mudaliar, Robert R Henry
Mar 9, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Yumei YeYochai Birnbaum
Apr 29, 2010·British Journal of Pharmacology·S Moncada
Nov 20, 2010·Cardiovascular Drugs and Therapy·Barbara HuisamenAmanda Lochner
Mar 15, 2011·Vascular Pharmacology·Zubair ShahSanjay Rajagopalan
Jun 15, 2011·Vascular Pharmacology·Gian Paolo Fadini, Angelo Avogaro
Aug 30, 2011·Journal of Molecular and Cellular Cardiology·M LenskiU Laufs
Nov 3, 2011·European Journal of Heart Failure·Nelson GomezKathleen Mc Entee
Jan 31, 2012·International Journal of Cardiology·Kroekkiat ChindaNipon Chattipakorn
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
Mar 29, 2012·Heart Failure Reviews·Takayuki MikiTetsuji Miura
Jun 19, 2012·The American Journal of Cardiology·Harshal R PatilJames H O'Keefe
Oct 11, 2012·PLoS Biology·Gorka BasañezJ Marie Hardwick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.